Pillars Articles

IN VIVO ANTIBODIES FROM BIO X CELLRecombinant PD-1: Consistent performance from pilot studies through translational researchPD-1 (CD279) is a central immune checkpoint receptor that downregulates T cell activity to maintain tolerance and prevent autoimmunity. By...

Introducing tumor cell lines   At abm, they offer an extensive collection of tumor cell lines that serve as ideal in vitro models for cancer research and therapeutic drug development. Their portfolio includes unique mouse, human, canine, and other mammalian cell...

IN VIVO ANTIBODIES FROM BIO X CELLInVivoPlus anti-mouse CD40 Catalog #BP0016-2Probing CD40 Signaling in Autoimmunity and Immuno-Oncology CD40 is a critical costimulatory receptor for B cell activation and autoantibody production. Agonist antibodies such as FGK4.5...

Download application note: Differentiation of induced pluripotent stem cells (iPSCs) into neuroectodermThe differentiation of feeder-free human induced pluripotent stem cells (iPSCs) into neuroectodermal cells is a complex process that uses growth factors such as...